12:00 AM
Jun 11, 2012
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Quest Diagnostics sales and marketing update

Quest launched its Quest Diagnostics Thyroid Cancer Mutation Panel in the U.S. to detect cancer in thyroid biopsies that were indeterminate for cancer based on cytology test methods. The panel identifies mutations...

Read the full 136 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >